-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Better Therapeutics, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from 2020 to 2022.
- Better Therapeutics, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2022 was $822 K, a 23% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly Data (USD)